Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NDRA

ENDRA Life Sciences (NDRA)

ENDRA Life Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NDRA
DateTimeSourceHeadlineSymbolCompany
2:22PMiHub NewswireFeatured1847 Announces $1.95 Million Repayment of Convertible Notes
02/21/20248:00AMBusiness WireNew ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS SystemNASDAQ:NDRAENDRA Life Sciences Inc
02/14/20248:30AMBusiness WireENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with New Patents in U.S., China and EuropeNASDAQ:NDRAENDRA Life Sciences Inc
12/29/20235:07PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NDRAENDRA Life Sciences Inc
11/29/20238:00AMBusiness WireENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System TechnologyNASDAQ:NDRAENDRA Life Sciences Inc
11/27/20238:00AMBusiness WireENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor ConferenceNASDAQ:NDRAENDRA Life Sciences Inc
11/14/20234:05PMBusiness WireENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
11/14/20234:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
11/08/20238:00AMBusiness WireENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New PatentsNASDAQ:NDRAENDRA Life Sciences Inc
11/07/20234:05PMBusiness WireENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023NASDAQ:NDRAENDRA Life Sciences Inc
11/06/20238:00AMBusiness WireENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023NASDAQ:NDRAENDRA Life Sciences Inc
09/07/20238:00AMBusiness WireAbstract for ENDRA Life Sciences' TAEUS System Accepted for Presentation at EASL Steatotic Liver Disease Summit 2023NASDAQ:NDRAENDRA Life Sciences Inc
08/30/20238:00AMBusiness WireENDRA Life Sciences' TAEUS De Novo Submission Advances to Next Stage of Review with FDANASDAQ:NDRAENDRA Life Sciences Inc
08/23/20238:00AMBusiness WireENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European PatentsNASDAQ:NDRAENDRA Life Sciences Inc
08/14/20234:53PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NDRAENDRA Life Sciences Inc
08/14/20234:45PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NDRAENDRA Life Sciences Inc
08/14/20234:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
08/14/20234:05PMBusiness WireENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:NDRAENDRA Life Sciences Inc
08/14/20231:30PMBusiness WireENDRA Life Sciences Submits De Novo Request for its TAEUS® System Liver Fat Application to the U.S. FDANASDAQ:NDRAENDRA Life Sciences Inc
08/10/20238:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
08/01/20238:00AMBusiness WireENDRA Life Sciences to Report Second Quarter 2023 Financial Results on August 14, 2023NASDAQ:NDRAENDRA Life Sciences Inc
07/25/20234:03PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NDRAENDRA Life Sciences Inc
07/25/20234:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
07/06/20235:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NDRAENDRA Life Sciences Inc
07/06/20235:25PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NDRAENDRA Life Sciences Inc
07/06/20234:45PMBusiness WireENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023NASDAQ:NDRAENDRA Life Sciences Inc
06/07/20238:00AMBusiness WireStudy Highlighting ENDRA Life Sciences’ TAEUS Technology to be Presented at EASL International Liver Congress 2023NASDAQ:NDRAENDRA Life Sciences Inc
05/24/20234:30PMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:NDRAENDRA Life Sciences Inc
05/24/20234:22PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NDRAENDRA Life Sciences Inc
05/24/20234:11PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NDRAENDRA Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:NDRA